Eisai Co. unveiled much-anticipated findings on its experimental Alzheimer’s drug, providing tinder for the hot debate over whether its modest efficacy is worth potential risks that include serious brain bleeding. … Click to Continue »
Lawsuit claims Miami overcharged building permit fees for years, seeks $76 million... 